🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 4 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/01/2005 | 21,25 | 21,78 | 21,21 | 21,28 | +0,00% | 2,68% | 740.000 |
| 07/01/2005 | 21,69 | 22,00 | 21,28 | 21,28 | -1,89% | 3,32% | 937.800 |
| 06/01/2005 | 21,31 | 21,84 | 21,18 | 21,69 | +1,52% | 3,12% | 662.200 |
| 05/01/2005 | 21,05 | 21,70 | 20,93 | 21,37 | +0,78% | 3,68% | 744.800 |
| 04/01/2005 | 22,05 | 22,26 | 20,97 | 21,20 | -3,75% | 5,83% | 1.335.800 |
| 03/01/2005 | 22,80 | 22,80 | 21,75 | 22,03 | -2,44% | 4,63% | 1.097.200 |
| 31/12/2004 | 22,76 | 22,92 | 22,52 | 22,58 | -1,10% | 1,78% | 377.000 |
| 30/12/2004 | 22,43 | 22,95 | 22,35 | 22,83 | -1,60% | 2,65% | 582.400 |
| 29/12/2004 | 23,28 | 23,80 | 22,96 | 23,20 | -0,73% | 3,61% | 1.228.600 |
| 28/12/2004 | 22,68 | 23,48 | 22,37 | 23,37 | +3,94% | 4,89% | 1.346.400 |
| 27/12/2004 | 22,48 | 22,71 | 22,48 | 22,48 | +0,04% | 1,05% | 1.133.800 |
| 23/12/2004 | 22,64 | 22,65 | 22,37 | 22,47 | -0,66% | 1,24% | 352.200 |
| 22/12/2004 | 22,13 | 22,73 | 22,11 | 22,62 | +1,69% | 2,78% | 581.400 |
| 21/12/2004 | 22,50 | 22,85 | 22,07 | 22,25 | -0,38% | 3,47% | 611.400 |
| 20/12/2004 | 22,50 | 22,61 | 22,19 | 22,33 | -0,18% | 1,87% | 645.800 |
| 17/12/2004 | 22,21 | 22,54 | 22,20 | 22,37 | +0,99% | 1,53% | 855.800 |
| 16/12/2004 | 22,44 | 22,55 | 22,03 | 22,15 | -0,98% | 2,30% | 955.000 |
| 15/12/2004 | 22,55 | 22,61 | 22,30 | 22,37 | -0,47% | 1,37% | 1.074.400 |
| 14/12/2004 | 21,85 | 22,69 | 21,85 | 22,48 | +2,86% | 3,84% | 1.989.800 |
| 13/12/2004 | 21,50 | 21,88 | 21,41 | 21,85 | +1,72% | 2,19% | 505.800 |
| 10/12/2004 | 21,30 | 21,58 | 21,30 | 21,48 | +0,42% | 1,29% | 873.600 |
| 09/12/2004 | 20,89 | 21,80 | 20,77 | 21,39 | +1,35% | 4,93% | 2.302.600 |
| 08/12/2004 | 21,04 | 21,16 | 20,73 | 21,11 | +0,02% | 2,04% | 1.124.400 |
| 07/12/2004 | 21,95 | 22,01 | 21,03 | 21,10 | -3,76% | 4,46% | 1.049.600 |
| 06/12/2004 | 22,50 | 22,50 | 21,73 | 21,93 | -2,56% | 3,44% | 694.200 |
| 03/12/2004 | 22,45 | 22,85 | 22,33 | 22,50 | +0,20% | 2,34% | 782.800 |
| 02/12/2004 | 22,19 | 22,50 | 22,15 | 22,46 | +0,83% | 1,58% | 745.000 |
| 01/12/2004 | 21,94 | 22,55 | 21,88 | 22,27 | +1,20% | 3,05% | 1.627.000 |
| 30/11/2004 | 21,89 | 22,48 | 21,44 | 22,01 | +0,14% | 4,73% | 1.455.000 |
| 29/11/2004 | 23,63 | 23,63 | 21,56 | 21,98 | -3,43% | 8,76% | 4.930.400 |